The 14 patients with a grade 3 astrocytoma, IDH-mutant of the surgery group were matched with 14 patients with a grade 3 astrocytoma, IDH-mutant of the oncological group. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).